RecruitingNot applicableNCT05951101
Zenith LAA Occlusion System
Studying Hereditary atrial fibrillation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AuriGen Medical Ltd
- Principal Investigator
- Felix MahfoudInternal Medicine and Cardiology, Saarland University Hospital
- Intervention
- Zenith LAA Occlusion System(device)
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2025
Study locations (3)
- The Royal Melbourne Hospital, Parkville, Victoria, Australia
- Auckland City Hospital, Auckland, New Zealand
- Christchurch Hospital, Christchurch, New Zealand
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05951101 on ClinicalTrials.govOther trials for Hereditary atrial fibrillation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06578104PULSED AF Post-Approval StudyMedtronic Cardiac Ablation Solutions
- RECRUITINGNCT05190679Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial FibrillationVanderbilt University Medical Center
- RECRUITINGPHASE3NCT04045665Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGIcahn School of Medicine at Mount Sinai